A carregar...
IMMU-53. CO-ADMINISTRATION OF DEXAMETHASONE WITH CHECKPOINT BLOCKADE THERAPY INCREASES SURVIVAL IN BRAIN TUMOR MODEL
BACKGROUND: The use of corticosteroids for therapeutic benefit must be weighed against risks of adverse consequences associated with these drugs. Brain tumor patients are routinely prescribed dexamethasone to reduce tumor-associated edema. Checkpoint blockade, a type of immune therapy, is currently...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692480/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.511 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|